Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)

製品コード:A2856        

印刷

Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)  is a gut‐selective humanized monoclonal antibody targets β7 integrins with a potential to treat inflammatory bowel disease (IBD). MW: 144.3 KD.

製品説明

CAS No. 1044758-60-2
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。